Cargando…

Therapeutic use of pulsed electromagnetic field therapy reduces prostate volume and lower urinary tract symptoms in benign prostatic hyperplasia

BACKGROUND: Benign prostatic hyperplasia (BPH) etiology remains poorly understood, but chronic low‐grade inflammation plays a role. Pulsed electromagnetic field therapy (PEMF) (1‐50 Hz) is effective in reducing tissue inflammation. OBJECTIVES: We designed a pilot study to evaluate the effects of PEM...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tenuta, Marta, Tarsitano, Maria G., Mazzotta, Paola, Lucchini, Livia, Sesti, Franz, Fattorini, Giorgio, Pozza, Carlotta, Olivieri, Valerio, Naro, Fabio, Gianfrilli, Daniele, Lenzi, Andrea, Isidori, Andrea M., Pofi, Riccardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496682/ https://www.ncbi.nlm.nih.gov/pubmed/32090492 http://dx.doi.org/10.1111/andr.12775

Ejemplares similares

SUN-238 Clinical Presentation, Management And Follow-up Of 83 Leydig Cell Tumors Of The Testis: A Prospective Case-cohort Study.
por: Isidori, Andrea, et al.
Publicado: (2019)

Clinical presentation, management and follow-up of 83 patients with Leydig cell tumors of the testis: a prospective case-cohort study
por: Pozza, Carlotta, et al.
Publicado: (2019)

Use of contrast enhanced ultrasound in testicular diseases: A comprehensive review
por: Tenuta, Marta, et al.
Publicado: (2021)

Testicular ultrasound score: A new proposal for a scoring system to predict testicular function
por: Pozza, Carlotta, et al.
Publicado: (2020)

Testicular Dysfunction in 47,XXY Boys: When It All Begins. A Semilongitudinal Study
por: Pozza, Carlotta, et al.
Publicado: (2023)

Sex Steroid Metabolism in Benign and Malignant Intact Prostate Biopsies: Individual Profiling of Prostate Intracrinology
por: Gianfrilli, Daniele, et al.
Publicado: (2014)

cAMP-specific phosphodiesterase 8A and 8B isoforms are differentially expressed in human testis and Leydig cell tumor
por: Campolo, Federica, et al.
Publicado: (2022)

OR21-6 Diabetic Cardiac Hypertrophy Is Associated With Viscoelastic Changes In Myocardial Contraction: Role Of Hsa-mir-122-5p On Extracellular Matrix.
por: Isidori, Andrea, et al.
Publicado: (2019)

Benign Prostatic Hyperplasia
Publicado: (2015)

Phosphodiesterase-5 inhibition preserves renal hemodynamics and function in mice with diabetic kidney disease by modulating miR-22 and BMP7
por: Pofi, Riccardo, et al.
Publicado: (2017)

LBMON274 Total Osteocalcin Levels Are Independently Associated With Worse Testicular Function And A Higher Degree Of HPG Axis Activation In Klinefelter Syndrome
por: Carlomagno, Francesco, et al.
Publicado: (2022)

Pulsed electromagnetic field with or without exercise therapy in the treatment of benign prostatic hyperplasia
por: Elgohary, Hany M, et al.
Publicado: (2017)

Testosterone and benign prostatic hyperplasia
por: Jarvis, Thomas R, et al.
Publicado: (2015)

A Novel MAX Gene Mutation Variant in a Patient With Multiple and “Composite” Neuroendocrine–Neuroblastic Tumors
por: Pozza, Carlotta, et al.
Publicado: (2020)

Prostatitis and benign prostatic hyperplasia: emerging infectious diseases?
por: Hennenfent, B
Publicado: (1997)

Zinc status in benign prostatic hyperplasia and prostate carcinoma
por: Wiwanitkit, Somsri, et al.
Publicado: (2012)

Silodosin in the treatment of benign prostatic hyperplasia
por: Rossi, Maxime, et al.
Publicado: (2010)

Management of benign prostatic hyperplasia with silodosin
por: Yamanishi, Tomonori, et al.
Publicado: (2009)

Pathophysiology of clinical benign prostatic hyperplasia
por: Foo, Keong Tatt
Publicado: (2017)

Epidemiology of clinical benign prostatic hyperplasia
por: Lim, Kok Bin
Publicado: (2017)

Botulinum toxin and benign prostatic hyperplasia
por: Ng, Lay Guat
Publicado: (2018)

Solving the benign prostatic hyperplasia puzzle
por: Foo, Keong Tatt
Publicado: (2016)

Tissue microenvironment and benign prostatic hyperplasia
por: Wei, Xing, et al.
Publicado: (2019)

Synergistic interaction of benign prostatic hyperplasia and prostatitis on prostate cancer risk
por: Hung, S-C, et al.
Publicado: (2013)

Zinc status of patients with benign prostatic hyperplasia and prostate carcinoma
por: Christudoss, Pamela, et al.
Publicado: (2011)

Expression and Localization of Aquaporins in Benign Prostate Hyperplasia and Prostate Cancer
por: Hwang, Insang, et al.
Publicado: (2012)

Urinary microbiota in patients with prostate cancer and benign prostatic hyperplasia
por: Yu, Haining, et al.
Publicado: (2015)

Rare Variant of Carcinoma Prostate Masquerading as Benign Prostatic Hyperplasia
por: Khanduri, Sachin, et al.
Publicado: (2019)

Prostate sarcomas: A radiological mimic for benign prostatic hyperplasia
por: Whish-Wilson, Thomas, et al.
Publicado: (2020)

Prostate embolization in the treatment of benign prostatic hyperplasia: what’s the point?
por: Nunes, Thiago Franchi, et al.
Publicado: (2021)

Heat Shock Proteins in Benign Prostatic Hyperplasia and Prostate Cancer
por: Ratajczak, Weronika, et al.
Publicado: (2022)

Shared Inherited Genetics of Benign Prostatic Hyperplasia and Prostate Cancer
por: Glaser, Alexander, et al.
Publicado: (2022)

Linking Pre-Diabetes with Benign Prostate Hyperplasia. IGFBP-3: A Conductor of Benign Prostate Hyperplasia Development Orchestra?
por: Protopsaltis, Ioannis, et al.
Publicado: (2013)

Impact of Benign Prostatic Hyperplasia and/or Prostatitis on the Risk of Prostate Cancer in Korean Patients
por: Kim, Sung Han, et al.
Publicado: (2021)

Holmium laser ablation of the prostate (HoLAP) with moses technology for the surgical treatment of benign prostatic hyperplasia
por: Grosso, Antonio Andrea, et al.
Publicado: (2021)

Robot-assisted simple prostatectomy for giant benign prostatic hyperplasia
por: Carbonara, Umberto, et al.
Publicado: (2020)

Multiparametric Ultrasound for Diagnosing Testicular Lesions: Everything You Need to Know in Daily Clinical Practice
por: Pozza, Carlotta, et al.
Publicado: (2023)

Morphological Changes of Benign Prostatic Hyperplasia in Culture
por: McMahon, M. J., et al.
Publicado: (1973)

Benign Prostatic Hyperplasia: from Bench to Clinic
por: Yoo, Tag Keun, et al.
Publicado: (2012)

VASTI THERAPY IN THE MANAGEMENT OF BENIGN PROSTATE HYPERPLASIA
por: Gupta, Shivaji, et al.
Publicado: (1997)

Cannot write session to /tmp/vufind_sessions/sess_0acfoabkeonncr2oc2mkk4cd48